Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1497-04

Crosseal, fibrin sealant (human), This package***, One Applicator, Two Vial cups, Sterile, Disposable, Single...

Omrix Biopharmaceuticals, Ltd. - Plasma Fract. Inst. / initiated 2004-08-06 / Terminated

Omrix Biopharmaceuticals, Ltd. - Plasma Fract. Inst. began a recall of Crosseal, fibrin sealant (human), This package***, One Applicator, Two Vial cups, Sterile, Disposable, Single Use, For Usage***, Rx Only, Distributed by... on . The reason FDA records is "5 mL Crosseal fibrin sealant (human) is difficult to expel from the device resulting in product leakage from the vial insertion port". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1497-04
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Omrix Biopharmaceuticals, Ltd. - Plasma Fract. Inst.
Product
Crosseal, fibrin sealant (human), This package***, One Applicator, Two Vial cups, Sterile, Disposable, Single Use, For Usage***, Rx Only, Distributed by American Red Cross Blood Services, Washington, DC 20006, Manufactured by: Medimop Medical Projects Ltd, for OMRIX biopharmaceuticals, Utd, MDA blood bank, Sheba Hospital, Romat-Gan, PO8 888, Kiryat Ono 55000 Israel
Product code
FMF Syringe, Piston
Reason for recall
5 mL Crosseal fibrin sealant (human) is difficult to expel from the device resulting in product leakage from the vial insertion port .
FDA root cause
Other
Action
American Red Cross was notified of the recall on July 25, 2004. Recall letter to the ARC direct accounts was sent out on 8/9/2004.
Distribution
The product was shipped from Israel to the American Red Cross distribution center in Louisville, KY. From there, the ARC would ship the product to other distributors and/or directly to 46 hospitals nationwide. There are no govt accounts.
Product codes and lots
Lot 0404 exp. Oct. 2008; Lot 0417 exp. Jan. 2009; Lot 0419 exp. Jan. 2009.